CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: Using a transwell assay, CD4 and CD8 T cells had a significant reduction in migration towards CCL19 and CCL21, powerful chemoattractants, in CML patients post-intake compared to pre-intake (Colom-Fernández et al., 2019).